Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD

被引:11
作者
Johnson, Kate M. [1 ]
Safari, Abdollah [1 ,2 ]
Tan, Wan C. [3 ]
Bourbeau, Jean [4 ]
FitzGerald, J. Mark [2 ]
Sadatsafavi, Mohsen [1 ,2 ,5 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver Campus,2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Inst Heart & Lung Hlth, Dept Med, Vancouver, BC, Canada
[3] St Pauls Hosp, Ctr Heart Lung Innovat, James Hogg Res Ctr, Vancouver, BC, Canada
[4] McGill Univ, Ctr Hlth, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada
[5] Vancouver Coastal Hlth Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
population; respiratory symptoms; chronic obstructive pulmonary disease; variability; cough; phlegm; wheeze; dyspnea; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; LUNG-FUNCTION; VARIABILITY; IMPACT; EXACERBATION; ASSOCIATION; DECLINE;
D O I
10.2147/COPD.S184424
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated with this heterogeneity are not well understood. Methods: A sample of the general Canadian population >= 40 years with persistent airflow limitation was followed for up to 3 years. Participants reported whether they experienced chronic coughing, phlegm, wheezing, or dyspnea during visits at 18-month intervals. We used mixed-effect logistic regression models (separately for each symptom) to assess overall heterogeneity in the occurrence of symptoms between individuals, and the proportion of variation in symptom burden explained by lung function vs all other clinical characteristics of participants. Results: Four hundred forty-nine participants (53% male, mean age 67 years) contributed 968 visits in total, and 89% of patients reported at least one symptom during follow-up. There was substantial heterogeneity in the individual-specific probabilities for the occurrence of symptoms. This heterogeneity was highest for wheeze and dyspnea (IQR of probabilities: 0.13-0.78 and 0.19-0.81, respectively). FEV1 explained 28% of the variation between individuals in the occurrence of dyspnea, 8% for phlegm, 3% for cough, and 2% for wheeze. All clinical characteristics of participants (including FEV1) explained between 26% of heterogeneity in the occurrence of cough to 49% for dyspnea. Conclusion: There is marked heterogeneity in the burden of respiratory symptoms between COPD patients. The ability of lung function and other commonly measured clinical characteristics to explain this heterogeneity differs between symptoms.
引用
收藏
页码:3983 / 3994
页数:12
相关论文
共 30 条
[1]   Global and regional estimates of COPD prevalence: Systematic review and meta-analysis [J].
Adeloye, Davies ;
Chua, Stephen ;
Lee, Chinwei ;
Basquill, Catriona ;
Papana, Angeliki ;
Theodoratou, Evropi ;
Nair, Harish ;
Gasevic, Danijela ;
Sridhar, Devi ;
Campbell, Harry ;
Chan, Kit Yee ;
Sheikh, Aziz ;
Rudan, Igor .
JOURNAL OF GLOBAL HEALTH, 2015, 5 (02) :186-202
[2]   Characterisation of COPD heterogeneity in the ECLIPSE cohort [J].
Agusti, Alvar ;
Calverley, Peter M. A. ;
Celli, Bartolome ;
Coxson, Harvey O. ;
Edwards, Lisa D. ;
Lomas, David A. ;
MacNee, William ;
Miller, Bruce E. ;
Rennard, Steve ;
Silverman, Edwin K. ;
Tal-Singer, Ruth ;
Wouters, Emiel ;
Yates, Julie C. ;
Vestbo, Jorgen .
RESPIRATORY RESEARCH, 2010, 11
[3]   Methods for evaluation of medication adherence and persistence using automated databases [J].
Andrade, Susan E. ;
Kahler, Kristijan H. ;
Frech, Feride ;
Chan, K. Arnold .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (08) :565-574
[4]  
[Anonymous], 2020, Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2020 report
[5]   Somatic symptom reporting in women and men [J].
Barsky, AJ ;
Peekna, HM ;
Borus, JF .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (04) :266-275
[6]   Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the Need for Longitudinal Observational Studies in COPD [J].
Bourbeau, Jean ;
Tan, Wan C. ;
Benedetti, Andrea ;
Aaron, Shawn D. ;
Chapman, Kenneth R. ;
Coxson, Harvey O. ;
Cowie, Robert ;
Fitzgerald, Mark ;
Goldstein, Roger ;
Hernandez, Paul ;
Leipsic, Jonathon ;
Maltais, Francois ;
Marciniuk, Darcy ;
O'Donnell, Denis ;
Sin, Don D. .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 11 (02) :125-132
[7]  
Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724
[8]   Influence of Season on Exacerbation Characteristics in Patients With COPD [J].
Donaldson, Gavin C. ;
Goldring, James J. ;
Wedzicha, Jadwiga A. .
CHEST, 2012, 141 (01) :94-100
[9]   Variability of Respiratory Symptoms in Severe COPD [J].
Espinosa de los Monteros, Maria Jose ;
Pena, Carolina ;
Soto Hurtado, Enrique Javier ;
Jareno, Javier ;
Miravitlles, Marc .
ARCHIVOS DE BRONCONEUMOLOGIA, 2012, 48 (01) :3-7
[10]   NATURAL-HISTORY OF CHRONIC AIR-FLOW OBSTRUCTION [J].
FLETCHER, C ;
PETO, R .
BMJ-BRITISH MEDICAL JOURNAL, 1977, 1 (6077) :1645-1648